Logo image of NWH-DB-H.CA

NORTHWEST HEALTHCARE PRO (NWH-DB-H.CA) Stock Price, Quote, News and Overview

TSX:NWH-DB-H - Toronto Stock Exchange - CA667495AJ41 - Currency: CAD

100.01  +0.01 (+0.01%)

Fundamental Rating

3

Taking everything into account, NWH-DB-H scores 3 out of 10 in our fundamental rating. NWH-DB-H was compared to 38 industry peers in the Diversified REITs industry. NWH-DB-H has a medium profitability rating, but doesn't score so well on its financial health evaluation. NWH-DB-H does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

NWH-DB-H had negative earnings in the past year.
NWH-DB-H had a positive operating cash flow in the past year.
In multiple years NWH-DB-H reported negative net income over the last 5 years.
Each year in the past 5 years NWH-DB-H had a positive operating cash flow.
NWH-DB-H.CA Yearly Net Income VS EBIT VS OCF VS FCFNWH-DB-H.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

NWH-DB-H has a Return On Assets of -4.90%. This is in the lower half of the industry: NWH-DB-H underperforms 71.05% of its industry peers.
NWH-DB-H has a Return On Equity of -18.89%. This is in the lower half of the industry: NWH-DB-H underperforms 73.68% of its industry peers.
The Return On Invested Capital of NWH-DB-H (4.59%) is better than 81.58% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NWH-DB-H is below the industry average of 5.66%.
The last Return On Invested Capital (4.59%) for NWH-DB-H is above the 3 year average (3.39%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -4.9%
ROE -18.89%
ROIC 4.59%
ROA(3y)-2.92%
ROA(5y)0.56%
ROE(3y)-11.33%
ROE(5y)0.68%
ROIC(3y)3.39%
ROIC(5y)3.39%
NWH-DB-H.CA Yearly ROA, ROE, ROICNWH-DB-H.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

With an excellent Operating Margin value of 61.65%, NWH-DB-H belongs to the best of the industry, outperforming 84.21% of the companies in the same industry.
In the last couple of years the Operating Margin of NWH-DB-H has declined.
NWH-DB-H has a Gross Margin of 74.31%. This is amongst the best in the industry. NWH-DB-H outperforms 84.21% of its industry peers.
NWH-DB-H's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 61.65%
PM (TTM) N/A
GM 74.31%
OM growth 3Y-1.83%
OM growth 5Y-2.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.75%
GM growth 5Y-0.16%
NWH-DB-H.CA Yearly Profit, Operating, Gross MarginsNWH-DB-H.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NWH-DB-H is destroying value.
The number of shares outstanding for NWH-DB-H has been increased compared to 1 year ago.
Compared to 5 years ago, NWH-DB-H has more shares outstanding
Compared to 1 year ago, NWH-DB-H has an improved debt to assets ratio.
NWH-DB-H.CA Yearly Shares OutstandingNWH-DB-H.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
NWH-DB-H.CA Yearly Total Debt VS Total AssetsNWH-DB-H.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

NWH-DB-H has an Altman-Z score of 3.32. This indicates that NWH-DB-H is financially healthy and has little risk of bankruptcy at the moment.
NWH-DB-H has a better Altman-Z score (3.32) than 92.11% of its industry peers.
The Debt to FCF ratio of NWH-DB-H is 34.13, which is on the high side as it means it would take NWH-DB-H, 34.13 years of fcf income to pay off all of its debts.
NWH-DB-H's Debt to FCF ratio of 34.13 is on the low side compared to the rest of the industry. NWH-DB-H is outperformed by 71.05% of its industry peers.
NWH-DB-H has a Debt/Equity ratio of 1.64. This is a high value indicating a heavy dependency on external financing.
NWH-DB-H has a Debt to Equity ratio of 1.64. This is in the lower half of the industry: NWH-DB-H underperforms 71.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.64
Debt/FCF 34.13
Altman-Z 3.32
ROIC/WACC0.59
WACC7.78%
NWH-DB-H.CA Yearly LT Debt VS Equity VS FCFNWH-DB-H.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

NWH-DB-H has a Current Ratio of 0.19. This is a bad value and indicates that NWH-DB-H is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.19, NWH-DB-H is in line with its industry, outperforming 42.11% of the companies in the same industry.
A Quick Ratio of 0.19 indicates that NWH-DB-H may have some problems paying its short term obligations.
The Quick ratio of NWH-DB-H (0.19) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.19
NWH-DB-H.CA Yearly Current Assets VS Current LiabilitesNWH-DB-H.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

1

3. Growth

3.1 Past

The earnings per share for NWH-DB-H have decreased by -0.29% in the last year.
Looking at the last year, NWH-DB-H shows a quite strong growth in Revenue. The Revenue has grown by 13.40% in the last year.
NWH-DB-H shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.78% yearly.
EPS 1Y (TTM)-0.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.14%
Revenue 1Y (TTM)13.4%
Revenue growth 3Y7.27%
Revenue growth 5Y4.78%
Sales Q2Q%-16.4%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NWH-DB-H.CA Yearly Revenue VS EstimatesNWH-DB-H.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
NWH-DB-H.CA Yearly EPS VS EstimatesNWH-DB-H.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0.5 1 1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NWH-DB-H reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NWH-DB-H.CA Price Earnings VS Forward Price EarningsNWH-DB-H.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as NWH-DB-H.
Based on the Price/Free Cash Flow ratio, NWH-DB-H is valued expensively inside the industry as 89.47% of the companies are valued cheaper.
Industry RankSector Rank
P/FCF 276.15
EV/EBITDA 77.96
NWH-DB-H.CA Per share dataNWH-DB-H.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

NWH-DB-H has a Yearly Dividend Yield of 10.04%, which is a nice return.
Compared to an average industry Dividend Yield of 7.95, NWH-DB-H pays a better dividend. On top of this NWH-DB-H pays more dividend than 92.11% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.42, NWH-DB-H pays a better dividend.
Industry RankSector Rank
Dividend Yield 10.04%

5.2 History

The dividend of NWH-DB-H decreases each year by -13.72%.
NWH-DB-H is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)-13.72%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of NWH-DB-H are negative and hence is the payout ratio. NWH-DB-H will probably not be able to sustain this dividend level.
DP-25.96%
EPS Next 2YN/A
EPS Next 3YN/A
NWH-DB-H.CA Yearly Income VS Free CF VS DividendNWH-DB-H.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

More info and screens

NORTHWEST HEALTHCARE PRO

TSX:NWH-DB-H (6/30/2025, 7:00:00 PM)

100.01

+0.01 (+0.01%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)05-14 2025-05-14
Earnings (Next)08-11 2025-08-11
Inst Owners20.51%
Inst Owner ChangeN/A
Ins Owners0.25%
Ins Owner ChangeN/A
Market Cap24.82B
Analysts72
Price Target115.53 (15.52%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 10.04%
Yearly Dividend0.32
Dividend Growth(5Y)-13.72%
DP-25.96%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.85%
PT rev (3m)1.02%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 43.24
P/FCF 276.15
P/OCF 271.73
P/B 15.6
P/tB 16.49
EV/EBITDA 77.96
EPS(TTM)-1.22
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.36
FCFY0.36%
OCF(TTM)0.37
OCFY0.37%
SpS2.31
BVpS6.41
TBVpS6.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.9%
ROE -18.89%
ROCE 6.37%
ROIC 4.59%
ROICexc 4.65%
ROICexgc 4.73%
OM 61.65%
PM (TTM) N/A
GM 74.31%
FCFM 15.66%
ROA(3y)-2.92%
ROA(5y)0.56%
ROE(3y)-11.33%
ROE(5y)0.68%
ROIC(3y)3.39%
ROIC(5y)3.39%
ROICexc(3y)3.42%
ROICexc(5y)3.44%
ROICexgc(3y)3.49%
ROICexgc(5y)3.51%
ROCE(3y)4.7%
ROCE(5y)4.71%
ROICexcg growth 3Y5.86%
ROICexcg growth 5Y0.71%
ROICexc growth 3Y6.01%
ROICexc growth 5Y0.84%
OM growth 3Y-1.83%
OM growth 5Y-2.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.75%
GM growth 5Y-0.16%
F-Score4
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 1.64
Debt/FCF 34.13
Debt/EBITDA 7.32
Cap/Depr 39.56%
Cap/Sales 0.25%
Interest Coverage 2.08
Cash Conversion 25.55%
Profit Quality N/A
Current Ratio 0.19
Quick Ratio 0.19
Altman-Z 3.32
F-Score4
WACC7.78%
ROIC/WACC0.59
Cap/Depr(3y)24.87%
Cap/Depr(5y)24.57%
Cap/Sales(3y)0.11%
Cap/Sales(5y)0.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-0.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.4%
Revenue growth 3Y7.27%
Revenue growth 5Y4.78%
Sales Q2Q%-16.4%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y8.38%
EBIT growth 3Y5.3%
EBIT growth 5Y2.61%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-53.4%
FCF growth 3Y-11.68%
FCF growth 5Y-7.73%
OCF growth 1Y-52.74%
OCF growth 3Y-11.5%
OCF growth 5Y-7.59%